Limaca Medical Introduces Innovative Precision-GI™ Device
Breaking into the US Market with Precision-GI™
Limaca Medical Ltd. has achieved a significant milestone by launching its Precision-GI™ endoscopic automated motorized biopsy device in the US market. This exciting development is the result of successful clinical trials, FDA clearance, and securing CMS Transitional Pass-Through (TPT) Payment. Such a robust foundation positions Limaca effectively for its market entry.
Revolutionizing Biopsy Procedures
The Precision-GI™ device is crafted to enhance biopsy outcomes for patients suspected of having cancers in the gastrointestinal tract and adjacent organs, such as the pancreas and liver. The innovative automated, rotating cutting mechanism of this device allows for superior tissue acquisition, which is essential for meticulous histopathologic and molecular analysis. It minimizes blood content in samples while operating far more efficiently in a single pass.
Impressive Clinical Trial Outcomes
Dr. Carlos Robles-Medranda and his team at the IECED Medical Center conducted an extensive clinical trial involving 40 patients. The focus was primarily on endoscopic ultrasound-guided biopsies for solid pancreatic masses, as well as biopsies of other masses within or adjacent to the GI tract. The results were impressive, showcasing the Precision-GI™ device's capability to provide consistent, high-quality biopsy samples.
Dr. Robles-Medranda shared that using the Precision-GI™ is notably straightforward for physicians, yielding phenomenal results with just one pass. The core samples collected were neither fragmented nor bloody, reflecting the high quality now achievable in the biopsy process.
Expanding Market Presence
Limaca Medical is strategically focusing its sales efforts in major metropolitan areas. The company has onboarded Michael Davis, an experienced medical device sales director, to fortify their sales resources in the US market. Notably, hospitals across the New York Metro area are showing keen interest. They aim to adopt the Precision-GI™ device, facilitated by the TPT designation reimbursement status, which provides vital financial support for their integration.
Insights from Experienced Professionals
Dr. Rosario Ligresti, a leading gastroenterologist at Hackensack Medical Center, has already conducted over twenty cases utilizing the Precision-GI™ device. He expressed enthusiasm about partnering with Limaca, emphasizing the range of successful biopsies performed, including those from lymph nodes and pancreatic masses.
A Vision for the Future
According to Assaf Klein, CEO of Limaca, the progress made in the past year places the company at the forefront of innovative endoscopic biopsy solutions. Limaca is poised for significant growth as it continues to develop superior diagnostic tools that lead to better outcomes for patients and enhanced experiences for physicians.
About Limaca Medical Ltd.
Limaca Medical Ltd. is a privately held company committed to enhancing endoscopic biopsy solutions for patients facing serious cancer diagnoses. The company’s research and development efforts are backed by various investors, including the Israeli Innovation Authority and seasoned veterans in the medical device industry. Limaca collaborates with HekaBio, a Japan-based healthcare innovation company, to expand its market reach and technological advancements.
Contact Information
For inquiries, reach out to Assaf Klein, CEO, at Assaf@limaca-medical.com.
Frequently Asked Questions
What is the Precision-GI™ device?
The Precision-GI™ device is an endoscopic automated motorized biopsy system designed to improve biopsy results for patients with suspected GI cancers.
How does the device enhance biopsy procedures?
Precision-GI™ utilizes a motorized cutting mechanism that allows for superior tissue acquisition with minimal blood, yielding high-quality samples efficiently.
Where has Limaca launched this device?
Limaca has launched the Precision-GI™ device in the US market, particularly focusing on the New York Metro area.
What type of support does the TPT designation provide?
The TPT designation helps hospitals financially with reimbursements, facilitating the purchase and integration of Precision-GI™ devices into their systems.
Who can be contacted for more details regarding Limaca Medical?
Assaf Klein, the CEO of Limaca Medical, can be contacted via email at Assaf@limaca-medical.com for more information.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.